ADBIOTECH to issue Convertible Bonds
애드바이오텍
179530
Signal Score
Historical Avg Return (5d)
+0.00%
Data Coverage
100%n=2547
Risk-adjusted indicator based on 2547 historical DART filings. For informational purposes only — not investment advice.
Financial Impact
NEGATIVE
Key Numbers
- • Early redemption rate: 103.00% (June 5, 2027) to 115.08% (March 5, 2031)
- • ETRON Co., Ltd. (Major Shareholder of target entity): Total Assets 345,611M KRW (2025)
- • ETRON Co., Ltd. (Major Shareholder of target entity): Net Income 49,460M KRW (2025)
- • ETRON Co., Ltd. (Major Shareholder of target entity): Auditor's Opinion 'Disclaimer of Opinion' (2025)
AI Analysis Summary
ADBIOTECH Co., Ltd. has decided to issue convertible bonds. While the specific total amount, conversion price, and number of shares to be issued are not disclosed in this report, the early redemption rates range from 103.00% on June 5, 2027, to 115.08% on March 5, 2031. The report also details financial information for ETRON Co., Ltd., a major shareholder of a related entity, showing 2025 total assets of 345,611M KRW and net income of 49,460M KRW, but with a 'Disclaimer of Opinion' from its auditor. The lack of key issuance details and the auditor's opinion for a related entity suggest potential risks and dilution for existing shareholders.
How This Event Is Evaluated
Capital Raise Evaluation
Capital raise events are evaluated by estimating dilution pressure, funding purpose, pricing terms, and impact on existing shareholders.
AI is used to interpret disclosures and extract structured data.
Signal scores are generated using event-specific methodologies and quantitative models.
- Potential dilution rate
- Issuance or conversion price
- Funding purpose
- Shareholder value impact
Track Korean Market Signals — Free
Sign up free to access live disclosures, AI analysis, and event filters.
Public Beta · No credit card required
This content is for informational purposes only and does not constitute investment advice. Past signal patterns do not guarantee future results. All data is sourced from public DART filings.